HIGHLIGHTS
- who: Giovanni de Nola and collaborators from the Department of Molecular Medicine, University of Pavia, Unit of Immunology and General Pathology Section, Pavia, Italy University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR, CIIL, Center for Infection and Immunity of Lille, Lille, France University of Lille, Inserm, CHU Lille, INFINITE, Institute for Translational Research in Inflammation, Lille, France Roche Pharmaceutical Research and Early Development (pRED), Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy , University of Lille, CNRS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.